rituximab chronic lymphocytic leukemia
Link Title
Link Short URL
Link Long URL
Description:
Rituximab mainly is a monoclonal antibody that depletes B-cells from the circulation. This medication was originally introduced to treat lymphoma but is increasingly recommended to treat patients with autoimmune diseases. The recommended rituximab dose should be administered as an intravenous (IV) infusion. (An infusion specifically is an injection into a vein that's given over a period of time.) by a healthcare professional.
Keywords (Tags):
No keywords provided.
Created by:
genericmedicine
Created on:
Hits:
537
|